Eight Capital Partners Plc (ECP) Stock: Price, News, Forecast and Analysis

Eight Capital Partners Plc is back on the radar of small-cap fintech investors after a turbulent two years marked by delayed accounts, trading suspensions, a radical balance-sheet clean‑up and a new leadership team. As of early December 2025, the London‑listed Aquis stock (ticker: ECP / ECPE, cross‑listed as ECS0 in Frankfurt) is trading around the 80p level and positioning itself as a niche play on European SME digital banking and lending. ^[1]

Share price snapshot and trading context (December 2025)

On the Aquis Stock Exchange company page, Eight Capital Partners shows a mid price of 79.5p, with a 52‑week range of 32.5p to 120p and a market capitalisation of about £37.3 million. The last recorded trades on 1 December 2025 were at 80p for 238,454 shares, underlining that this is still a relatively illiquid micro-cap despite chunky prints when blocks do trade. ^[2]

Investing.com reports the same 79.5p level, a 1‑year share price change of roughly –29%, and average three‑month volume of only around 2.4k shares, reinforcing the point that liquidity is thin and price moves can be abrupt. ^[3]

In Germany, the Frankfurt‑quoted line ECS0 trades at about €0.60, with a 52‑week range of €0.27–€4.00 and a 1‑year decline of about 70%, according to Simply Wall St. ^[4] The big gap between the 52‑week high and current level across both markets highlights just how volatile the name has been over the last year.

Aquis also shows 46.86 million tradable securities post‑consolidation, which is consistent with the company’s capital reorganisation but not with some legacy data feeds that still quote the pre‑consolidation share count. For investors, the Aquis and official RNS numbers are the ones to treat as current. ^[5]

What does Eight Capital Partners actually do?

Eight Capital Partners styles itself as an international financial services operating company focused on fintech operations – ranging from the digitisation of banking services to blockchain‑backed decentralised finance and digital lending platforms. ^[6]

The group’s current structure is straightforward but highly concentrated:

It operates one main subsidiary, Epsion Capital, an independent corporate advisory firm based in London specializing in UK and European capital markets, M&A and equity capital markets advisory. ^[7]
Strategically, the group wants to build a fintech banking and digital lending ecosystem for European SMEs, including digital bank services and trade‑receivables finance. ^[8]

In short, this is not a mainstream retail bank but a micro‑cap holding company with advisory revenues and a portfolio of financial instruments and projects in and around digital finance.

2025 news timeline: from suspension to “new phase of development”

As of 2 December 2025, there have been no new RNS announcements on the day itself. The most recent regulatory and newsflow items come from mid‑November and October 2025, plus the H1 results in September and the full‑year 2024 numbers in July. ^[9]

November 2025: AGM date and board change

On 17 November 2025, Eight Capital issued an RNS titled “Annual General Meeting and Directorate Change.” ^[10]

Key points:

The AGM for the year ended 31 December 2024 will be held at 11:00 a.m. GMT on 16 December 2025 at Cairn Financial Advisers’ offices in London (80 Cheapside, EC2V 6EE). ^[11]
Dominic White will step down as Non‑Executive Director at the AGM due to increasing commitments elsewhere but will continue to support the company as an adviser, working with the board on “new strategic initiatives” expected to be announced “shortly.” ^[12]
Executive Chairman Federico Bazzoni framed this as the start of a “new phase of development”, with a focus on launching new projects in the UK, wider Europe and the Middle East and strengthening the company’s market position. ^[13]

This is effectively a signal that Eight Capital wants to pivot from balance‑sheet repair to growth execution, with the leadership baton clearly passed to the new executive team installed in October.

October 2025: New executive leadership team

On 20 October 2025, the company announced a major board overhaul under the RNS titled “Directorate Change.” ^[14]

Highlights:

Appointment of Federico Bazzoni as Executive Chairman.
Appointment of Luca Giacomo Zanni as Executive Director.
Appointment of Bruce Chandler Gonyea as Independent Non‑Executive Director. ^[15]
Martin Groak and Luciano Maranzana stepped down from the board, while Dominic White moved into a Non‑Executive Director role (later transitioning to adviser at the AGM). ^[16]

The RNS gives unusually detailed CVs:

Bazzoni has held senior investment‑banking roles at Vantage Capital Markets Hong Kong, CITIC Securities, Bear Stearns and BNP Paribas, with a career heavily weighted towards capital markets in Asia and EMEA. ^[17]
Zanni is a career CFO, having worked at industrial and packaging groups with revenues up to €650m (including GPack, Safe and Fimer). ^[18]
Gonyea combines academic finance (Assistant Professor at Marian University) with earlier equity research and portfolio management roles at Société Générale and Caveco (a forerunner of GaveKal). ^[19]

Shares reportedly rose around 5% on the day of the announcement, according to RTT News, a rare show of enthusiasm for a stock that has mostly drifted sideways‑to‑down over the year. ^[20]

September 2025: H1 2025 – back to profit

The half‑year report to 30 June 2025 marked the company’s return to profitability, both in headline terms and at pre‑tax level. ^[21]

According to an Investing.com summary of the interim results:

Profit before tax: £0.903m, versus an operating loss in the first half of 2024. ^[22]
Revenue: £0.07m, up sharply from just £0.003m in H1 2024, reflecting increased transaction-led activity at Epsion Capital. ^[23]
Costs were slashed: general expenses down to £0.179m (from £0.375m), staff costs to £0.024m (from £0.108m) and legal/professional fees to £0.050m (from £0.159m). ^[24]
The big swing factor was a foreign exchange gain of £1.189m on euro‑denominated financial instruments, versus a £0.535m FX loss in the prior period. ^[25]
Net assets jumped to £33.1m at 30 June 2025, from £11.5m a year earlier, largely due to the partial write‑back of financial instruments received when the company sold its 1AF2 bond. ^[26]

The interim statement also notes:

A January 2025 capital reorganisation, cutting the share count from 187.45 billion (pre‑consolidation) to 46.86 million shares of 40p nominal value. ^[27]
Conversion of €1.08m of 4.8% bonds due 2026 into 810,325 ordinary shares, eliminating the outstanding bond liability. ^[28]
Full disposal of its stake in Evrima plc.
Ongoing negotiations involving a potential investment in a European bank and talks with senior professionals regarding further board and management hires. ^[29]

The pattern is clear: the profit figure is real, but it is heavily driven by FX and valuation adjustments on financial instruments, not by a surge in underlying advisory revenue.

July 2025: Full‑year 2024 – a dramatic turnaround

On 29 July 2025, Eight Capital reported a profit of £18.3m for the year ended 31 December 2024, compared with a loss of £18.9m in 2023. ^[30]

Key drivers, again summarised by Investing.com:

A £20.5m fair‑value gain on investments, mainly linked to the Settlement Financial Instruments received when Eight Capital sold its 1AF2 bond holding in December 2024. ^[31]
Revenue fell to £48k from £602k in 2023, with subsidiary Epsion Capital continuing to earn mainly M&A advisory fees. ^[32]
Net assets increased to £31.3m at year‑end 2024 from £12.8m in 2023, while cash balances were just £4k, highlighting a capital‑rich but still cash‑light balance sheet. ^[33]
The company eliminated its remaining corporate debt by converting bonds into equity and completed a share consolidation in early 2025, leaving it effectively debt‑free. ^[34]

Importantly, the financial statements carried a qualified audit opinion concerning the carrying value of the Settlement Financial Instruments – a reminder that a large part of the reported profit is driven by fair‑value marks on relatively opaque assets rather than recurring cash earnings. ^[35]

2025 suspensions and capital reorganisation glitches

The path to that “cleaner” balance sheet has been rocky:

On 30 June 2025, Eight Capital announced that trading in its shares would be suspended from 1 July due to a delay in publishing the 2024 audited annual report, missing the AQSE Growth Market deadline. Trading was to resume once the final results were released. ^[36]
Earlier, on 30 January 2025, a technical error disrupted the planned share consolidation and bond conversion, prompting a temporary suspension. Trading was expected to resume the next day, with new ordinary shares and bond shares admitted on 31 January 2025, and CREST accounts credited shortly afterwards. ^[37]

These repeated suspensions – combined with earlier delays in the 2023 accounts – are part of why some data providers and analysts have flagged “financial data availability” and historical going‑concern concerns as risk factors, even though the 2024 and H1 2025 numbers show a transformed balance sheet. ^[38]

Fundamentals and valuation: cheap on paper, complex in reality

Because this is a micro‑cap with thin coverage, different data providers disagree on the exact multiples – but there are some broad themes.

Balance sheet and profitability

Across Simply Wall St and Investing.com:

Market cap is in the £30–80m / €29m range, depending on which share‑count and FX assumptions a site uses; the post‑consolidation Aquis figure of ~£37.3m is the most consistent with RNS disclosures. ^[39]
Net assets were £31.3m at 31 Dec 2024 and £33.1m at 30 Jun 2025 – broadly in line with the market cap, suggesting the stock trades around book value. ^[40]
Trailing‑twelve‑month revenue is only about £137k, while earnings are ~£20.5m, implying an extraordinary net profit margin above 10,000% – a statistical artifact of huge one‑off valuation gains on a small revenue base. ^[41]
Debt is minimal; Simply Wall St cites a debt‑to‑equity ratio of around 0.08%, consistent with the company’s claim to be effectively debt‑free after bond conversions. ^[42]

Valuation metrics

The valuation picture depends heavily on whether you trust the fair‑value marks:

Simply Wall St gives Eight Capital a P/E ratio of ~1.2x and argues the stock is trading at an 86% discount to its intrinsic value under their model – making it screen as deeply “undervalued.” ^[43]
Investing.com, using different assumptions, shows a P/E of about 14.3x, price‑to‑book of ~0.76x, and book value per share of roughly £0.71, again implying the stock trades slightly below book value but nowhere near “1x earnings.” ^[44]

Both sources agree on some fundamentals:

The company is profitable on a trailing basis (“became profitable this year”), but earnings are dominated by large one‑off items. ^[45]
Revenue is under USD$1m/£0.14m, making this effectively an advisory boutique with a large financial‑asset portfolio attached. ^[46]

The tension here is obvious: on pure reported earnings, the stock can look extraordinarily cheap; once you adjust for the non‑recurring nature of those gains and the opacity of the instruments involved, the picture is much more nuanced.

Forecasts and external analysis

One of the most important facts for potential investors: there is effectively no mainstream broker coverage.

Simply Wall St explicitly notes that Eight Capital Partners is covered by 0 sell‑side analysts, and that no analysts have submitted revenue or earnings estimates into their model. ^[47]
Investing.com’s “Analysts Sentiment” section for ECPE is listed as “currently not supported”; some Pro features mention that “analysts anticipate sales decline in the current year,” but the underlying numbers are behind a paywall and do not represent a consensus from multiple banks. ^[48]

Publicly visible “forecasts” are therefore mostly:

Quant or rules‑based fair‑value models (e.g., discounted cash flow using historical data and generic assumptions).
Risk flags, including:
- Highly volatile share price over the past three months.
- Very small revenue base relative to earnings and market cap.
- Large one‑off items impacting financial results.
- Small market capitalisation and thin liquidity. ^[49]

In other words: there is no widely accepted price target or broker consensus for ECP. Any forward view is essentially an investor’s own scenario analysis on:

Whether the fair‑value gains on financial instruments are sustainable or repeatable.
Whether Epsion Capital – and any future fintech assets – can grow revenue meaningfully.
How credible the new management team is in executing the “new phase of development” described in the November RNS. ^[50]

Key risks to watch

Based on the company’s history and third‑party analysis, several risk themes stand out:

Reporting and governance track record
- Repeated delays in publishing accounts have led to trading suspensions in both 2023 and 2025. ^[51]
- The 2024 accounts carried a qualified audit opinion on the valuation of Settlement Financial Instruments, highlighting uncertainty around the carrying value of key assets. ^[52]
Earnings quality
- A large share of recent profits comes from fair‑value gains and FX movements, not from recurring operating cash flow. ^[53]
- Core fee revenue remains very small, making performance sensitive to deal‑flow timing and market conditions.
Volatility and liquidity
- Simply Wall St notes that ECS0’s weekly price volatility is significantly higher than most German stocks, and the one‑year share price performance has badly lagged both the German capital‑markets industry and the wider market. ^[54]
- Aquis data show low average volumes, meaning investors face wide spreads and potential price gaps. ^[55]
Micro‑cap concentration risk
- The company has one operating subsidiary and a relatively small team; key‑person and execution risk are non‑trivial. ^[56]

Potential catalysts and what could move the share price next

Looking forward from 2 December 2025, several events could act as catalysts:

AGM on 16 December 2025
- Management has signalled a “new phase of development” and “new strategic initiatives” to be announced. Details on projects in the UK, Europe and the Middle East – and how they will be funded – will be crucial in assessing whether Eight Capital can evolve from a balance‑sheet story into a genuine growth platform. ^[57]
Clarity on the European bank investment and other pipeline deals
- The H1 2025 interim statement mentions ongoing negotiations around a potential investment in a European bank and discussions with senior professionals to beef up the board and transaction capabilities. Any concrete deal announcement here would be material. ^[58]
Evidence of recurring revenue growth at Epsion Capital
- Even modest growth in advisory fees and transaction revenue could help diversify earnings away from one‑off valuation gains and strengthen the case for a higher quality, more sustainable earnings base. ^[59]
Improved reporting rhythm
- Delivering future results on time, without further suspensions or qualified audit opinions, would gradually rebuild trust with the market and may reduce the “governance discount” that many micro‑caps carry. ^[60]

Bottom line: an intricate micro‑cap fintech play

As of early December 2025, Eight Capital Partners sits in an unusual position:

Financially it now looks solid on paper: debt largely eliminated, net assets roughly in line with market value, and strong headline profits in 2024 and H1 2025.
Operationally it is still small, with limited recurring revenue and a business model that leans heavily on capital‑markets expertise and opportunistic investments.
From a valuation perspective, multiple data providers suggest the shares trade around or below book value and potentially at a steep discount to modelled intrinsic value – but those models rest on fair‑value marks that carry real uncertainty. ^[61]

For investors scanning Google News or Discover for “Eight Capital Partners share price,” “ECP stock forecast” or “ECPE analysis”, the key takeaway is that this is a high‑risk, high‑complexity micro‑cap rather than a straightforward fintech growth stock. Any decision to buy, sell or hold should factor in:

The history of reporting delays and suspensions.
The heavy reliance on non‑recurring valuation gains.
Thin liquidity and volatile price action.
The credibility of the new leadership team and their ability to turn a cleaned‑up balance sheet into a genuinely scalable fintech platform.